# Using Blood and Saliva mRNA to Detect Breast Cancer

> This patent describes a method using specific messenger RNA (mRNA) levels in blood or saliva to help detect breast cancer or determine its prognosis.

- **Patent:** US 20240117444
- **Original title:** Biomarkers for the diagnosis of breast cancer
- **Owner:** Mammogen
- **Status:** Active
- **Times cited:** 1
- **Field:** biotech, pharmaceutical, medical_devices, diagnostics

## What it does

This patent outlines a method for detecting breast cancer or predicting its outcome. It involves measuring the levels of at least one specific type of molecule called messenger RNA (mRNA) in a sample from a person, like blood or saliva. These measured levels are then sent to a computer and compared to a baseline level from a healthy sample. If the mRNA levels are different, it can indicate the presence of breast cancer or help doctors understand how aggressive it might be. The patent lists 26 specific mRNAs that can be used, and suggests using a combination of them to create a 'biomarker fingerprint' for more accurate diagnosis or prognosis. It also mentions using this information to guide treatment decisions and distinguish between different stages of the cancer.

## What it does NOT cover

- Detecting breast cancer using only imaging techniques like mammograms.
- Diagnosing breast cancer based on physical examination alone.
- Using protein levels or DNA mutations as the primary diagnostic markers.
- Methods that do not involve measuring mRNA expression levels.
- Detecting cancers other than breast cancer.

## The clever bit

The innovation lies in identifying and utilizing a specific panel of 26 mRNA molecules whose expression levels in blood or saliva are significantly altered in the presence of breast cancer, creating a unique 'fingerprint' for diagnosis and prognosis.

## Real-world examples

1. Mammogen Inc.'s diagnostic tests
2. Blood-based cancer screening technologies
3. Saliva-based diagnostic assays

## Why it matters

Early and accurate detection of breast cancer significantly improves treatment outcomes and patient survival rates. This patent offers a potential non-invasive method, using readily available samples like blood or saliva, to identify the disease or its likely progression. This could lead to earlier intervention and more personalized treatment strategies.

## Frequently asked questions

### What does Using Blood and Saliva mRNA to Detect Breast Cancer cover?

This patent describes a method using specific messenger RNA (mRNA) levels in blood or saliva to help detect breast cancer or determine its prognosis.

### Who owns patent US 20240117444?

This patent is owned by Mammogen.

### When does this patent expire?

This patent is expected to expire on February 11, 2042, when the invention enters the public domain.

### What is patent US 20240117444 cited by?

This patent has been cited by 1 later patents that build on its ideas.

### What problem does this patent solve?

Early and accurate detection of breast cancer significantly improves treatment outcomes and patient survival rates. This patent offers a potential non-invasive method, using readily available samples like blood or saliva, to identify the disease or its likely progression. This could lead to earlier intervention and more personalized treatment strategies.

### What does this patent NOT cover?

Detecting breast cancer using only imaging techniques like mammograms.

**Full plain-English explainer:** https://patentbrief.org/patent/us/20240117444/biomarkers-for-the-diagnosis-of-breast-cancer

**Original patent:** https://patents.google.com/patent/US20240117444

---

_Source: PatentBrief — https://patentbrief.org. Patent facts are from public records; the plain-English explanation is PatentBrief's._


## Related patents

Semantically similar inventions in the PatentBrief corpus:

- [Method for Diagnosing Ovarian Cancer Using Biomarkers](https://patentbrief.org/patent/us/8053198/diagnostic-methods) — This patent describes a method to diagnose ovarian cancer by measuring specific protein levels in a patient's blood sample and comparing them to normal levels.
- [How to Diagnose Cancer Better Using Multiple Blood Markers and Patient Data](https://patentbrief.org/patent/us/20230274838/method-for-improving-disease-diagnosis-using-measured-analytes) — This patent describes a method for improving cancer diagnosis by combining measurements of several biological markers with patient-specific information like age or body mass, transforming them into a special score, and then comparing that score to a model of known cancer cases.
- [Using Blood Markers to Diagnose Stroke and Tell Its Type](https://patentbrief.org/patent/us/10914745/biomarker-based-methods-for-aiding-the-diagnosis-of-stroke) — This patent describes a two-step method for diagnosing a stroke and then determining if it's an ischemic stroke or a transient ischemic attack (TIA) by measuring specific protein levels in a patient's blood.
- [Finding Rare Genetic Changes in Blood Using DNA Fragments](https://patentbrief.org/patent/us/12735751/systems-and-methods-to-detect-rare-mutations-and-copy-number-variation) — This patent describes a system and method for detecting uncommon genetic mutations and changes in gene copy numbers from DNA fragments found freely in bodily fluids, like blood.
- [Detecting Alzheimer's Risk Early with a Blood Test and Brain Scan](https://patentbrief.org/patent/us/11193946/blood-biomarker-for-discerning-beta-amyloid-accumulation-in-brain) — This patent describes a two-step method to predict early Alzheimer's disease by first checking specific protein levels in a blood sample, and then, if certain markers are low, performing a brain scan to confirm amyloid beta buildup.
